探索精细化割敏感前列腺癌的治疗模式:治疗策略的演变
Haizhong Xu1,2, Jialin Guo1,2, Wenrui Peng1,2
1Department of Urology, The 940 Hospital of Joint Logistics Support force of Chinese People's Liberation Army, Lanzhou, China.
Frontiers in oncology
|March 2, 2026
概括
精细化割敏感前列腺癌 (omCSPC) 的管理正在发展. 像PSMA-PET/CT这样的先进成像和个性化治疗,包括局部疗法和新型全身药物,正在改善结果.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 医疗成像医学成像
背景情况:
- 化敏感性前列腺癌 (omCSPC) 是局部转移性疾病和广泛转移性疾病之间的中间阶段.
- 准确的诊断和量身定制的治疗对于改善omCSPC患者的治疗结果至关重要.
研究的目的:
- 审查目前关于OMCSPC诊断,治疗和生物标志物的证据.
- 引导个性化治疗策略,并提高omCSPC患者的临床结果.
主要方法:
- 综合文献综述,重点关注omCSPC.
- 对PSMA-PET/CT用于病变检测的分析.
- 评估不断发展的局部和系统治疗方式.
- 评估生物标志物的预后和预测价值.
主要成果:
- 通过PSMA-PET/CT,可以提高识别寡头转移性病变的准确性.
- omCSPC治疗已经从单独的雄激素缺乏疗法 (ADT) 转向组合疗法.
- 当地疗法 (放射治疗,手术) 越来越多地用于延缓进展.
- omCSPC与新兴的预后生物标志物呈现异质性,需要标准化.
结论:
- 对OMCSPC的管理需要采用多学科和个性化的方法.
- 对生物标志物的进一步研究和局部疗法的最佳整合至关重要.
- 改进的策略旨在提高患者的生活质量和长期生存率.
相关概念视频
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K